Skip to content
Pharmaceutical and biotech giant Pfizer joined by specialty vaccine company Valneva announced on Tuesday that they’ve started Phase 3 clinical study for Vaccine Against […]
Pfizer-Valneva’s Lyme disease vaccine enters phase 3 amid rising incidence Read More »
In a $5.4 billion deal that will boost its rare disease treatment business, Pfizer is buying the pioneer in treatments for sickle cell disease,
Global Blood Therapeutics acquisition to boost Pfizer’s sickle cell pipeline Read More »
Lyme disease is on the rise in rural America. There has been a 357% increase in the prevalence of Lyme disease in rural areas
Lyme disease increases but biotech battles back Read More »
As part of its $740 billion reconciliation deal, the Senate on Sunday, August 7, passed legislation with drug price controls. The Inflation Reduction Act,
Senate passes drug price controls; legislation would kill innovation, access Read More »
People with metastatic HER2-low breast cancer – whose tumors don’t have high levels of the protein – up until now had limited treatment options.
FDA approves Enhertu, first targeted therapy for HER2-low breast cancer Read More »
The Senate is about to vote on a bill that would put limits on how much drugs can cost. According to a new Vital
Senate to vote on drug price controls legislation Read More »
The United States currently has over 6,600 registered cases of monkeypox, 1,200 of which were reported in the past three days, POLITICO reported, leading
Monkeypox: U.S. declares state of emergency over high case numbers Read More »
Proposed drug price controls will disrupt the vibrant US biotech ecosystem, according to Vital Transformation CEO Duane Schulthess. He spoke during an online briefing
Drug price control plan will disrupt biotech ecosystem, expert says Read More »
In light of the Senate’s current push for medication price limits, research analyzes the EU’s and Japan’s experiences to see how rapidly price controls
The case of the EU and Japan: How price controls hurt biotech innovation Read More »
When the current monkeypox outbreak started, we already had efficient monkeypox vaccines and therapeutics thanks to industry collaborations with the federal government and preparedness
Experts urge quicker response amid rising monkeypox cases Read More »
